𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Complementary value of pulmonary angiography and mediastinoscopy in individualizing treatment for patients with lung cancer

✍ Scribed by Norman C. Delarue; Douglas E. Sanders; Steven A. Silverberg


Publisher
John Wiley and Sons
Year
1970
Tongue
English
Weight
722 KB
Volume
26
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Possible prognostic value of pulmonary a
✍ H. Bartsch; E. Hietanen; S. Petruzzelli; C. Giuntini; R. Saracci; A. Mussi; C. A πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 French βš– 486 KB

As prognosis in breast cancer patients has been related to the AHH activity in their breast tissue, we have conducted a similar analysis on pulmonary drug metabolizing enzymes as prognostic markers for male lung cancer patients, primarily investigated for other reasons. A subset of 50 patients with

The value of combined-modality therapy i
✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l

A phase II study of gemcitabine in patie
✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo